REQUEST A DEMO
Total
USD $0.00
Search more companies

Tehran Darou Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Tehran Darou Pharmaceutical Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The main activity of the Company is Manufacture and export, sale of pharmaceutical, health, cosmetics and chemical products, purchase of imported machine for production, packaging, modification or industrial change of materials, both inside or outside the country, preparation and purchase or import of raw materials in general, including raw materials Raw or half-made, etc.
The Company was established as a limtid ltd company under name LABORATUVAR MAYSIN COMPANY LIMITID on 22 April 1955 registered under registration number 4763 on 22 May 1955.
The Company changed its name to be Tehran Darou Companypublic joint stock on 24 May 1983.
The Company changed its legal form to be Private Joint Stock Company on 30 April 1986. and changed its again to be Public Joint Stock Company on 3 December1997.
The Company was listed in Tehran Stock Exchange on 21 March 1998 delisted from It on 23 July 2013.
The Company was listed in Iran Fara bourse on 16 September 2013
The Companyُs shares were traded in Tehran Stock Exchange for the first time on 4 September 1999 On 21 January 2014 the company s stock transactions were transferred to Iran Fara bourse
Mission
Belief in the confidence of young, experienced and skilled personnel in Tehran Pharmaceutical Company encourages us to enter the pharmaceutical markets in the hope of creating more light and a healthier tomorrow for the forthcoming of mankind.
With consistent steps in the way, We are looking for clear conditions for quality and safety, and we are proud of ourselves that we are moving in the direction of knowledge, modern and international conditions.
Values
Tehran Medical Center has always considered the following to seek high values, therefore:
- Innovation, honesty, hard work, perseverance and highest compliance with doing business and professional ethics.
- Using the latest technology in the world to do research, produce and provide new products and valuable services.
- Creating mutual trust among patients, clients, employees, shareholders and the community.
- Protection of intangible assets and assets of the company and other stakeholders
- Continuing education and improving the skills of all stakeholders in the organization
- Compliance with the latest national and international requirements and standards.
- Promote and encourage teamwork and individual efforts.
- Consider the human resources as the foundation of the organization, care and companionship with them at the best possible level.
- Organizational upgrade by relying on merit
Organization value:
In this regard, The Company divide values into three groups of organizational values, group values, and individual values:
Organizational Values:
Stockholders: Creating sustainable value for shareholders and community, trying to realize the right to expect and hold shareholders of the company and their satisfaction.
Customer Orientation :Develop a company and win-win relationships with business partners, highlighting the needs of customers and effectively communicating with them, and enhancing customer perspective in the organization
Healthy competition: Compliance with ethics and professionalism in competing with competing companies.
Environmental: Compliance with environmental standards and requirements
Social Responsibility: Commitment and Obligation to Improve Community Health Indicators.
Human relationships: Respecting employees as the main driver of development and growth.
Health and Safety: safety, health and participation, and diligence.
Quality improvement: Focus on continuously improving the quality of services and products, keeping up with the standards, emphasizing the quality and full compliance with legal requirements, especially the principles of GMP.
Company Profitability: Business Leadership and Innovation, Corporate Finance Growth with More Work and diligence.
Outlook (View) :
The Companyُs ideal is that they are one of the leading pioneers in the pharmaceutical industry to achieve superior product quality.
Achieving a prominent and valuable position for patients, customer, personnel, social partners, investors and for the community in which they live.

Headquarters
9Th .Km Of Karaj Makhsous Rd, Located In The Third Way Of Pars Khodro Next To Bank Mellat
Tehran; Tehran; Postal Code: 1399615851

Contact Details: Purchase the Tehran Darou Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.tehrandarou.com

Basic Information
Total Employees:
Purchase the Tehran Darou Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Tehran Darou Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Tehran Darou Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
1955
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
26%
Purchase this report to view the information.
17%
Purchase this report to view the information.
15%
Purchase this report to view the information.
10%
Purchase this report to view the information.
2%
Company Performance
Financial values in the chart are available after Tehran Darou Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
106.73%
Total operating revenue
106.79%
Operating profit (EBIT)
209.71%
EBITDA
207.06%
Net Profit (Loss) for the Period
179.64%
Total assets
94.87%
Total equity
132.59%
Operating Profit Margin (ROS)
12.29%
Net Profit Margin
5.16%
Return on Equity (ROE)
4.65%
Debt to Equity Ratio
-28.03%
Quick Ratio
0.08%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?